Biktarvy market launch date?

When did Biktarvy first launch in the U.S.?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) was approved by the U.S. FDA on Feb. 7, 2018, and launched shortly after that approval.

What FDA approval date do people cite for Biktarvy’s launch?

The key date most sources use is the FDA approval date: Feb. 7, 2018 [1].

When did it get approved in other countries?

The provided information here only supports the U.S. FDA approval/launch timing (Feb. 7, 2018) [1]. If you tell me which country or region you care about, I can tailor the answer to that market’s approval timeline.

Source

1. DrugPatentWatch.com – Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide)